Rocketing to a price of $11.66 during today's evening trading session, shares of Roivant Sciences are still -24.77% below their average target price of $15.5. Could there be more upside potential for the stock? Analysts are giving ROIV an average rating of buy and target prices ranging from $11.0 to $23.0 dollars per share.
For the greater market's outlook on the stock, we can use Roivant Sciences's short interest as a proxy. The short interest represents the proportion of the float's shares that are tied to short positions, meaning that the investor believes the stock will decline in the future. Here, the stock's short interest is 13.6% which means the outlook is split.
When a stock is sold short, it means an investor has borrowed shares of the stock from their broker, and then sold them at the going market price. The investor hopes for the price to decline, so that they might buy those shares back at a lower price in the future. Once they do, they can return the borrowed shares to their broker, and keep the profit they made on the transaction.
Another way to gauge the sentiment on Roivant Sciences is to look at the percentage of institutions that are invested in the stock. In this case, 58.5% of the shares are held by pension, mutual, and hedge funds, which shows that these institutions probably have strong confidence in the stock.
If institutions are invested in a particular stock, it shows in most cases that they have performed quality research and concluded that it is a good investment. In some cases, however, increases in institutional ownership could be a sign of a takeover attempt or proxy fight, which can actually injure share prices. Also, institutions are not infallible, and can certainly make miscalculations -- often with spectacular results.
Overall, there is positive market sentiment on Roivant Sciences because its an analyst consensus of strong upside potential, a buy rating, an above average percentage of its shares sold short, and an average number of institutional investors. Warren Buffett famously said that in the short term, markets are voting mechanisms, but in the long term, they are weighing mechanisms. This means that long term investors should be aware of a stock's fundamentals before committing.
Buffett was one of the fist investors to focus on free cash flow as a yardstick for a company's health. Here are ROIV's recent cash flows:
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cashflow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-02-13 | -677,729 | -17,436 | -660,293 | -20.86 |
| 2022-02-14 | -552,138 | -5,806 | -546,332 | n/a |
